Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2026 Jul 14;17:1916009. doi: 10.3389/fphar.2026.1916009

Correction: Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases

Jingxiu Chen 1,†, Chunhua Chen 1,†, Xiaobin Lin 1, Jiajia Yan 1, Yifan Zheng 1,2, Pan Chen 1,*, Jia Li 1,3,*
PMCID: PMC13408399  PMID: 42524035

Affiliation 3 was erroneously duplicated from affiliation 2. The correct affiliation 3 is Department of Pharmacy, Guangxi Hospital Division of the First Affiliated Hospital, Sun Yat-sen University, Nanning, China.

The original version of this article has been updated.

Footnotes

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES